Effect of Progressive Muscle Relaxation Exercises in Menopausal Women Experiencing RLS.

What this trial studies

Restless legs syndrome is a symptom that can be seen in all stages of a woman's life, but its frequency and severity increases with menopause. Restless legs syndrome is a neurological problem that occurs usually at night with an irresistible urge to move the legs. It is a progressive muscle relaxation exercise. Progressive muscle relaxation exercise is a systematic practice aimed at providing deep relaxation by exercising large muscle groups in the body along with breathing techniques.

Conditions in scope

• Restless Legs Syndrome

Interventions

• progressive muscle relaxation exercises (Behavioral) — Progressive muscle relaxation exercises (PKGE); 16 large muscles (right hand and forearm, right upper arm, left hand and forearm of left arm, left upper arm, forehead, upper cheek and nose, chin, neck, abdomen, upper right arm, which people can do…

Who can join

Women only · Adults (Child, Adult, Older Adult) · Accepts healthy volunteers.

Inclusion criteria

• Having entered natural menopause
• At least 1 year has passed since the last menstrual period
• Not having any psychiatric disease
• Not having any communication problems (mental, auditory, visual, etc.)

Exclusion criteria

• Women not performing post-test applications
• Not doing progressive muscle relaxation exercises twice in a row.
• Wants to quit the research.
• The woman is hospitalized
• Inability to reach women during follow-ups

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2023-12-25
• Primary completion: 2024-05-30
• Last update posted: 2024-09-26
• First posted: 2023-12-05

Sponsor & contact

Lead sponsor: Gazi University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Restless Legs Syndrome Severity (Change from Baseline RLS Severity at 8 weeks)
  Measurements will be made using the RLS Severity Rating Scale. A total score is obtained, with the entire score range varying between 0 and 40; A score between 1-10 indicates mild disease, a score between 11-20 indicates moderate disease, a score between 21-30 indicates severe disease, and a score between 31-40 indicates very severe disease.
• Quality of life associated with restless legs syndrome (Change from Baseline Quality of Life at 8 weeks)
  Measurements will be made using the Johns Hopkins Restless Leg Syndrome Quality of Life Scale. The lowest score from the scale is 0 and the highest score is 100. As the score obtained from the scale decreases, it indicates that the quality of life associated with restless legs syndrome is poor.
• Quality of sleep associated with restless legs syndrome (Change from Baseline Quality of Life at 8 weeks)
  Measurements will be made using the Pittsburg Sleep Quality Index.A high total score indicates poor sleep quality. Total score is between 0-21. The index does not indicate the presence or frequency of sleep disturbances. However, a PSQI total score of 5 or above indicates poor sleep quality. The cut-off score indicating poor sleep quality is accepted as 5.

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.